Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia (HDL)

This study has been completed.
Information provided by (Responsible Party):
Herbert Meltzer, Northwestern University Identifier:
First received: March 29, 2012
Last updated: December 8, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2015
  Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)